The use of cardiovascular system medicine in Chile has exhibited significant variation over the past decade. From a notable peak in 2014, the usage showed a fluctuating pattern with several declines until 2018. A resurgence began in 2019, continuing through 2023, where the metric stood at 600 units (Defined Daily Dosage) per thousand persons per day. The year-on-year variation indicates a strong growth in 2019 and 2020, followed by a more modest increase in recent years. The CAGR over the last five years leading up to 2023 was an impressive 10.74%, reflecting sustained growth.

Looking ahead, forecasted data suggests a continued growth pattern with an anticipated CAGR of 2.28% over the next five years. This translates to an 11.91% growth rate by 2028, indicating a slower but still positive trend.

Future trends to watch for include:

Advancements in cardiovascular treatments and innovations in pharmaceutical development
Improved healthcare access and policies aimed at preventing cardiovascular diseases
Demographic shifts such as aging population which may lead to increased medicine use